Evidence map›Paper›PMID 24068671›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathway.

Josephine Fernando, Travis W Faber, Nicholas A Pullen, Yves T Falanga, Elizabeth Motunrayo Kolawole, Carole A Oskeritzian, Brian O Barnstein, Geethani Bandara, Geqiang Li, Lawrence B Schwartz and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Human Umbilical Cord Mesenchymal Stem Cell Therapy Mitigates Interstitial Cystitis by Inhibiting Mast Cells.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. A New Target Organ ofFrontiers in cellular and infection microbiology · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. TGF-β1 Suppresses IL-33-Induced Mast Cell Function.Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Josephine FernandoDepartment of Biology, Virginia Commonwealth University, Richmond, VA 23284;
Travis W Faber
Nicholas A Pullen
Yves T Falanga
Elizabeth Motunrayo Kolawole
Carole A Oskeritzian
Brian O Barnstein
Geethani Bandara
Geqiang Li
Lawrence B Schwartz
Sarah Spiegel
David B Straus
Daniel H Conrad
Kevin D Bunting
John J Ryan
Virginia Commonwealth University · USBoston Children's Museum · USChildren's Healthcare of Atlanta · USNational Institutes of Health · US

Funding

The Effect of Lyn Deficiency on Mast Cell Activation and Inflammatory Disease ProU19AI077435 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI SCHWARTZ, LAWRENCE B. · 2008 to 2012
$7.7M
Virginia Commonwealth University IRADCAK12GM093857 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI DANIEL C BULLARD, John J Ryan · 2010 to 2026
$7.0M
STAT5 Structure-Function in HematopoiesisR01DK059380 · NIDDK · EMORY UNIVERSITY · PI BUNTING, KEVIN D · 2002 to 2017
$4.2M
IL-10 Regulates Mast Cell Function and SurvivalR01AI059638 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI RYAN, JOHN J · 2007 to 2017
$3.8M
Control of IgG-mediated Inflammation by Fyn and Lyn KinasesR01AI101153 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI RYAN, JOHN J · 2013 to 2017
$2.0M
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammationR01AI095494 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI OSKERITZIAN, CAROLE A · 2012 to 2015
$1.4M
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell FunctionsK01AR053186 · NIAMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI OSKERITZIAN, CAROLE A · 2006 to 2010
$522k
Mast Cell Function in Protective And Pathological Immunity: A Role for MDSC?R56AI097350 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI RYAN, JOHN J · 2012 to 2012
$336k
NIAID NIH HHS 1R01AI095494NIAID NIH HHS 1R01AI59638NIAID NIH HHS R01 AI059638NIAID NIH HHS R01 AI095494NIAID NIH HHS R01 AI101153NIAID NIH HHS R56 AI097350NIAID NIH HHS U19 AI077435NIAID NIH HHS U19AI077435NIAMS NIH HHS K01 AR053186NIAMS NIH HHS K01AR053186NIDDK NIH HHS 2R01DK059380NIDDK NIH HHS R01 DK059380NIGMS NIH HHS K12 GM093857
6 · The paper itself

Abstract

We previously demonstrated that TGF-β1 suppresses IgE-mediated signaling in human and mouse mast cells in vitro, an effect that correlated with decreased expression of the high-affinity IgE receptor, FcεRI. The in vivo effects of TGF-β1 and the means by which it suppresses mast cells have been less clear. This study shows that TGF-β1 suppresses FcεRI and c-Kit expression in vivo. By examining changes in cytokine production concurrent with FcεRI expression, we found that TGF-β1 suppresses TNF production independent of FcεRI levels. Rather, IgE-mediated signaling was altered. TGF-β1 significantly reduced expression of Fyn and Stat5, proteins critical for cytokine induction. These changes may partly explain the effects of TGF-β1, because Stat5B overexpression blocked TGF-mediated suppression of IgE-induced cytokine production. We also found that Stat5B is required for mast cell migration toward stem cell factor, and that TGF-β1 reduced this migration. We found evidence that genetic background may alter TGF responses. TGF-β1 greatly reduced mast cell numbers in Th1-prone C57BL/6, but not Th2-prone 129/Sv mice. Furthermore, TGF-β1 did not suppress IgE-induced cytokine release and did increase c-Kit-mediated migration in 129/Sv mast cells. These data correlated with high basal Fyn and Stat5 expression in 129/Sv cells, which was not reduced by TGF-β1 treatment. Finally, primary human mast cell populations also showed variable sensitivity to TGF-β1-mediated changes in Stat5 and IgE-mediated IL-6 secretion. We propose that TGF-β1 regulates mast cell homeostasis, and that this feedback suppression may be dependent on genetic context, predisposing some individuals to atopic disease.

Indexed as

AnimalsCell MovementCells, CulturedCytokinesHumansImmunoglobulin EMast CellsMiceMice, Inbred C57BLProto-Oncogene Proteins c-fynProto-Oncogene Proteins c-kitReceptors, IgERNA InterferenceRNA, Small InterferingSignal TransductionSTAT5 Transcription FactorCytokinesFCER1A protein, humanFyn protein, mouseImmunoglobulin EProto-Oncogene Proteins c-fynProto-Oncogene Proteins c-kitReceptors, IgERNA, Small InterferingStat5b protein, mouseSTAT5 Transcription FactorTransforming Growth Factor beta1Tumor Necrosis Factors

Identifiers

PMID24068671
PMCPMC3846427
OpenAlexW2114043889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.